Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,365
Total Claims
$1.1M
Drug Cost
689
Beneficiaries
$1,606
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-69%
Opioid rate vs peers
2.8% vs 9.2% avg
+123%
Cost per patient vs peers
$1,606 vs $719 avg
+73%
Brand preference vs peers
11.5% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.8%
Opioid Rate
294
Opioid Claims
$3,775
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,180 claims · $918K
Generic: 9,100 claims · $183K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 103 | $118K |
| Apixaban | 88 | $86K |
| Empagliflozin | 62 | $86K |
| Rivaroxaban | 47 | $62K |
| Insulin Glargine,hum.Rec.Anlog | 61 | $57K |
| Dulaglutide | 36 | $44K |
| Rifaximin | 13 | $44K |
| Fluticasone/Umeclidin/Vilanter | 44 | $36K |
| Insulin Lispro | 34 | $33K |
| Insulin Detemir | 23 | $31K |
| Linaclotide | 12 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 20 | $17K |
| Evolocumab | 19 | $15K |
| Budesonide/Formoterol Fumarate | 23 | $15K |
| Fluticasone Propionate | 18 | $15K |
Prescribing Profile
Patient Profile
71
Avg Age
48%
Female
1.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About